Your browser doesn't support javascript.
loading
Construction, purification, and characterization of anti-BAFF scFv-Fc fusion antibody expressed in CHO/dhfr- cells.
Cao, Meng; Cao, Peng; Yan, Huaijiang; Lu, Wuguang; Ren, Fang; Hu, Yunlong; Zhang, Shuangquan.
Affiliation
  • Cao M; Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, Life Sciences College, Nanjing Normal University, Nanjing, Jiangsu, 210046, People's Republic of China.
Appl Biochem Biotechnol ; 157(3): 562-74, 2009 Jun.
Article de En | MEDLINE | ID: mdl-19099209
ABSTRACT
Elevated levels of B-cell-activating factor of the tumor necrosis factor family (BAFF) have been implicated in the pathogenesis of autoimmune diseases in human. In this study, we have constructed a vector for the expression of a novel compact antibody composed of anti-BAFF single-chain antibody fragment (scFv) and the Fc region (the hinge region, CH2, and CH3 domains) of human IgG1 in Chinese hamster ovary cells. The scFv-Fc fusion protein, showing spontaneous Fc fragment-mediated homodimerization via disulfide bridges, was affinity-purified on protein A Sepharose from culture supernatant. The scFv-Fc antibody was demonstrated to retain high binding affinity to antigen and prolonged clearance time in blood and to possess some human IgG crystallizable fragment effector functions such as protein A binding and antibody-dependent cellular cytotoxicity. These results suggest that this recombinant antibody may have therapeutic applications in the therapy of autoimmune disorders mediated by BAFF.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines de fusion recombinantes / Fragments Fc des immunoglobulines / Fragments d'immunoglobuline / Facteur d'activation des lymphocytes B Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Appl Biochem Biotechnol Année: 2009 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines de fusion recombinantes / Fragments Fc des immunoglobulines / Fragments d'immunoglobuline / Facteur d'activation des lymphocytes B Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Appl Biochem Biotechnol Année: 2009 Type de document: Article
...